UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):March 12, 1996
THERAGENICS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State of Incorporation)
0-15443 58-1528626
(Commission File Number) (I.R.S. Employer Identification No.)
5325 Oakbrook Parkway, Norcross, Georgia 30093
(Address of Principal Executive Offices) (Zip Code)
(404) 381-8338
(Registrant's Telephone Number, Including Area Code)
<PAGE>
Item 5. Other Events
Announcement of Annual Meeting of Stockholders
Theragenics' Annual Meeting of Stockholders will be held Friday,
May 24, 1996, at 10:00 A.M., Atlanta time, at the Gwinnett Civic
& Cultural Center, 6400 Sugarloaf Parkway, Duluth, Georgia 30136.
The purpose of this meeting is to elect two directors (six
directors constitute the entire board), to consider and vote on a
proposal to ratify the appointment of independent public
accountants, and to transact other business as may properly come
before the meeting or any adjournments thereof. The Board of
Directors has fixed the close of business on March 29, 1996, as
the record date for the determination of the stockholders
entitled to notice of, and to vote at, the meeting. It is
anticipated that the Proxy Statement, Proxy and Annual Report
will be mailed to stockholders entitled to notice of and to vote
at the Annual Meeting on or about April 19, 1996.
This announcement serves to satisfy the public disclosure
requirement of the date of the Annual Meeting of Stockholders as
addressed in the By-Laws of Theragenics Corporation.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
THERAGENICS CORPORATION
/s/ Bruce W. Smith
Bruce W. Smith
Secretary, Treasurer and
Chief Financial Officer
Dated: March 12, 1996
